Early Access to Medicines Scheme
Merck’s targeted lung cancer drug tepotinib wins early access in UK
Phil Taylor
Early Access to Medicines Scheme, Merck KGaA, MHRA, NSCLC, Tabrecta, Tepmetko, UK
0 Comment
Cancer/ News/ News/ News/ Oncology/ Pharma Market Access/ R&D/ UK & Europe
BI drug named Promising Innovative Medicine in mesothelioma
Andrew McConaghie
Boehringer Ingelheim, Early Access to Medicines Scheme, mesothelioma, MHRA, Promising Innovative Medicine, UK market access, Vargatef
0 Comment
UK patients gain early access to Duchenne drug
Richard Staines
Duchenne muscular dystrophy, Early Access to Medicines Scheme, neurology, Rare diseases, regulation, Santhera, Sarepta
0 Comment
Patients to get Santhera’s Raxone under EAMS scheme.